According to reports, the axe is coming down all over the pharma world on research and development projects that are not yielding immediate results. AstraZeneca(Atacand, Crestor), GlaxoSmithKline (Advair, Boniva) and Pfizer (Benadryl, Lipitor) have all already begun to scrap projects, while others like Sanofi-Aventis (Allegra, Plavix) are about to pick up the trend and start [...]
Entries Tagged as 'GlaxoSmithKline'
Big Pharma making big cuts in R&D
February 8th, 2010 · 1 Comment
Tags: AstraZeneca · Big Pharma · GlaxoSmithKline · Pfizer · Pharmaceutical companies · Prescription drugs · Sanofi-Aventis
The Fosamax mistrial, and other options in osteoporosis medication
September 25th, 2009 · 1 Comment
Earlier this month, a closely-watched trial over the osteoporosis drug Fosamax ended in mistrial, to the frustration of nearly everyone involved. The trial was marked by great tension, with a deadlocked jury, reports of threats of physical violence, and a judge-ordered cooling-down period. What could cause such intense drama? Well, this was just one of [...]
Tags: Boniva · Drug safety · Eli Lilly · Fosamax · GlaxoSmithKline · Medical information · Merck · Prescription drugs · Roche · Sanofi-Aventis
An atypical antidepressant for atypical depression: Consider Wellbutrin if SSRIs have failed
August 30th, 2009 · No Comments
Major depressive disorder affects approximately 15 million American adults in the U.S. in a given year, and a first pharmacological line of defense is often a prescription for an SSRI such as Prozac, Celexa, or Zoloft. (These drugs have been favored since the late 1980s for the treatment of depression as they are generally well [...]
Tags: Anti Depression Medication · Buy prescriptions online · Canadian drugs · Depression Medication · Generic drugs · GlaxoSmithKline · Prescription drugs · Smoking · Wellbutrin
Was Tom Cruise right about antidepressants?
November 6th, 2008 · 1 Comment
A couple of years ago, actor Tom Cruise was dismissed as a kook for ranting against antidepressants and other psychiatric drugs. But in light of what we’re now learning about SSRIs, is it possible that we collectively owe Cruise an apology? First, let me say that I still think Cruise is an odd guy. And [...]
Tags: Anti Depression Medication · Depression Medication · GlaxoSmithKline · Lexapro · Paxil · Pharmaceutical companies · Prescription drugs · Wellbutrin
Audio of Glaxo CEO meltdown
May 20th, 2008 · No Comments
GlaxoSmithKline CEO JP Garnier is grilled relentlessly by a BCC radio reporter about the suppression of data that suggested the anti-depressant Paxil (Seroxat in the U.K.) increased the likelihood of teen suicides — and finally walks out of the interview. Here’s the 10-minute clip; the meltdown starts at about the seven-minute mark: More on the [...]
Tags: GlaxoSmithKline · Paxil · Seroxat
Avandia one vote away from elimination
October 30th, 2007 · 1 Comment
Sen. Charles Grassley, the ranking Republican on the Senate Finance Committee, says that the FDA’s Drug Safety Oversight Board voted 8-7 on Oct. 2 to keep the scandal-plagued diabetes drug Avandia on the market. The result was kept from the public. Wow, what a nailbiter. That’s enough to give Glaxo execs a heart attack (or [...]
Tags: Avandia · GlaxoSmithKline
Avandia gets black-boxed
August 15th, 2007 · No Comments
From HealthDay News: The widely used but controversial diabetes drug Avandia will now have a strong “black box” warning on its label, advising users of an increased risk of heart failure, the U.S. Food and Drug Administration announced late Tuesday. Another four diabetes drugs from the same class, including Actos, will also carry a similar [...]
Tags: Avandia · FDA · GlaxoSmithKline
Avandia’s latest side effect: $200 million in lost revenues for Glaxo
July 25th, 2007 · No Comments
Glaxo pulled a rabbit out of the hat in its earnings report today with a little misdirection. Per MarketWatch: GlaxoSmithKline on Wednesday took some of the attention away from disappointing sales of diabetes drugs by announcing it was lifting its stock buyback authorization to 12 billion pounds ($24.7 billion). Experts expected to see Glaxo report [...]
[Read more →]
Tags: Avandia · Diabetes · GlaxoSmithKline
With an Alli like this, who needs enemas?
July 5th, 2007 · No Comments
That’s my favorite line from the Mark Sisson’s Daily Apple post, “10 Great Alli Leaks, Oops, Links.” Check it out.
Tags: Alli · GlaxoSmithKline
Glaxo’s Alli: An Exxon Valdez in your pants
June 22nd, 2007 · 3 Comments
The new diet drug Alli, produced by GlaxoSmithKline, is selling fast. As you’ve probably seen in the news, it’s the first FDA-approved OTC weight-loss pill. What’s interesting to me is that Alli’s embarrassing side effects have done little to dissuade potential users from buying the product. Glaxo says to expect “gas with oily spotting” and [...]
Tags: Alli · GlaxoSmithKline